LLY

996.4

-0.46%↓

JNJ

243

-0.23%↓

ABBV

228.13

+0.39%↑

NVS

155.63

-3.52%↓

AZN

192.84

-1.3%↓

LLY

996.4

-0.46%↓

JNJ

243

-0.23%↓

ABBV

228.13

+0.39%↑

NVS

155.63

-3.52%↓

AZN

192.84

-1.3%↓

LLY

996.4

-0.46%↓

JNJ

243

-0.23%↓

ABBV

228.13

+0.39%↑

NVS

155.63

-3.52%↓

AZN

192.84

-1.3%↓

LLY

996.4

-0.46%↓

JNJ

243

-0.23%↓

ABBV

228.13

+0.39%↑

NVS

155.63

-3.52%↓

AZN

192.84

-1.3%↓

LLY

996.4

-0.46%↓

JNJ

243

-0.23%↓

ABBV

228.13

+0.39%↑

NVS

155.63

-3.52%↓

AZN

192.84

-1.3%↓

Search

Quest Diagnostics Inc

Ouvert

SecteurSoins de santé

200.8 0.19

Résumé

Variation du prix de l'action

24h

Actuel

Min

197.41

Max

201.57

Chiffres clés

By Trading Economics

Revenu

-14M

245M

Ventes

-10M

2.8B

P/E

Moyenne du Secteur

23.038

61.417

Rendement du dividende

1.61

Marge bénéficiaire

8.731

Employés

46,000

EBITDA

-146M

401M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+9.51% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

1.61%

2.40%

Prochains Résultats

21 avr. 2026

Date du Prochain Dividende

20 avr. 2026

Date du Prochain Détachement de Dividende

6 avr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

1B

22B

Ouverture précédente

200.61

Clôture précédente

200.8

Sentiment de l'Actualité

By Acuity

46%

54%

142 / 351 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Bullish Evidence

Quest Diagnostics Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

10 mars 2026, 20:38 UTC

Résultats

Oracle Raises 2027 Sales Outlook Amid AI Demand, Restructuring

10 mars 2026, 23:57 UTC

Market Talk

Global Equities Roundup: Market Talk

10 mars 2026, 23:57 UTC

Market Talk

Risks Rising on Australian Bank Valuation Multiples -- Market Talk

10 mars 2026, 23:47 UTC

Market Talk

Nikkei May Rise as Concerns About Energy Costs Ease -- Market Talk

10 mars 2026, 23:37 UTC

Acquisitions, Fusions, Rachats

Yangzijiang Shipbuilding to Acquire Poseidon Stake for US$825.7M

10 mars 2026, 23:37 UTC

Acquisitions, Fusions, Rachats

Yangzijiang Shipbuilding to Buy 10% Stake in Poseidon

10 mars 2026, 23:37 UTC

Acquisitions, Fusions, Rachats

Yangzijiang Shipbuilding to Fund Deal With Internal Cash Resources

10 mars 2026, 23:37 UTC

Acquisitions, Fusions, Rachats

Yangzijiang Shipbuilding to Buy Stake From Fairfax, Washington Family Affiliates

10 mars 2026, 23:35 UTC

Market Talk
Principaux Événements d'Actualité

Gold Edges Higher as It Faces Opposing Forces -- Market Talk

10 mars 2026, 23:06 UTC

Résultats

Oracle Raises 2027 Sales View as AI Demand Outpaces Supply -- Update

10 mars 2026, 22:51 UTC

Principaux Événements d'Actualité

Deleted Tweet From Energy Secretary Sends Oil Markets on Another Wild Ride -- Updated

10 mars 2026, 21:39 UTC

Acquisitions, Fusions, Rachats

Bill Ackman Has a Stroke of Genius. Buy His New Fund and Get Shares of His Pershing Square IPO. -- Barrons.com

10 mars 2026, 21:21 UTC

Résultats

Oracle Stock Jumps on Earnings Beat. Its Cloud Business Is Taking Over. -- Barrons.com

10 mars 2026, 21:15 UTC

Résultats

Franco-Nevada: 2026 Total GEOs Expected to Range From 510,000 to 570,000 Ounces

10 mars 2026, 21:15 UTC

Acquisitions, Fusions, Rachats

Paramount Skydance's Stock Fades. The Warner Bros. Merger Will Take Years to Pay Off, BofA Says. -- Barrons.com

10 mars 2026, 21:14 UTC

Résultats

Franco-Nevada: Methodology Replaces Previous Variable GEO Conversion Ratios Based on Prevailing Market Prices

10 mars 2026, 21:13 UTC

Résultats

Franco-Nevada: Beginning in 2026, Company Will Be Adopt Fixed GEO Conversion Ratios Based on the Pricing Assumptions Outlined in 2026 Guidance

10 mars 2026, 21:12 UTC

Résultats

Franco-Nevada 4Q Rev $597.3M >FNV

10 mars 2026, 21:12 UTC

Résultats

Franco-Nevada 4Q EPS $1.90

10 mars 2026, 20:57 UTC

Résultats

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 mars 2026, 20:50 UTC

Market Talk
Résultats

Tech, Media & Telecom Roundup: Market Talk

10 mars 2026, 20:44 UTC

Résultats

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 mars 2026, 20:34 UTC

Market Talk
Résultats

Global Equities Roundup: Market Talk

10 mars 2026, 20:34 UTC

Market Talk
Résultats

Oracle Building More Software for Less Money After Restructuring -- Market Talk

10 mars 2026, 20:23 UTC

Résultats

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 mars 2026, 20:16 UTC

Résultats

NIO Stock Jumps After Earnings. How the EV Maker Delivered a Surprise Profit. -- Barrons.com

10 mars 2026, 20:14 UTC

Résultats

Oracle Has Not Yet Initiated At-The-Market Equity Portion of Financing Program >ORCL

10 mars 2026, 20:14 UTC

Résultats

Oracle Said In February It Intends to Raise Up to $50 B Dollars in Debt and Equity Financing >ORCL

10 mars 2026, 20:13 UTC

Résultats

Oracle Raised $30 B Through Combination of Investment Grade Bonds and Mandatory Convertible Preferred Stk Within Days of Feb Announcement >ORCL

10 mars 2026, 20:12 UTC

Résultats

Oracle Stock Jumps on Earnings Beat -- Barrons.com

Comparaison

Variation de prix

Quest Diagnostics Inc prévision

Objectif de Prix

By TipRanks

9.51% hausse

Prévisions sur 12 Mois

Moyen 220 USD  9.51%

Haut 235 USD

Bas 210 USD

Basé sur 11 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

11 ratings

6

Achat

5

Maintien

0

Vente

Score Technique

By Trading Central

175.87 / 176.5Support & Résistance

Court Terme

Bullish Evidence

Moyen Terme

Strong Bullish Evidence

Long Terme

Weak Bullish Evidence

Sentiment

By Acuity

142 / 351Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Quest Diagnostics Inc

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
help-icon Live chat